Market Trends of Global Aesthetic Fillers Industry
Hyaluronic Acid Segment to Hold Significant Market Share During the Forecast Period
- Hyaluronic acid is a natural substance found in the human body. High concentrations of acid are present in soft connective tissues, the fluid surrounding the eyes, and some cartilage and skin tissue. The demand for hyaluronic acid in many personal and cosmetic products has increased with the rising focus on personal care worldwide. Additionally, various research studies related to the use of hyaluronic acid in various treatment procedures are also expected to drive the segment growth.
- Hyaluronic acid-based fillers have become the most used soft tissue filler augmentation agents over the past few years. The significant advantages of hyaluronic acid include a reduction in hypersensitivity reactions, the promotion of its adoption, and the contribution to market growth. For instance, as per an article published in the Journal of Cosmetic Dermatology in April 2022, hyaluronic acid (HA) fillers are widely used in facial rejuvenation and are safe in clinical practice. The incidence of delayed-onset hypersensitivity reactions to earlier non-animal stabilized HA (NASHA) fillers has been estimated at 0.02% to 0.4%.
- Similarly, in June 2022, an article published in the Emergency Medicine Journal stated that hyaluronic acid gels are significantly used in various therapeutic applications, including facial lipoatrophy, scarring, post-traumatic reconstruction, facial asymmetry, and congenital or acquired facial deformity. Thus, the high usage of hyaluronic acid in aesthetic procedures is expected to fuel its demand, thereby contributing to the segment's growth.
- Furthermore, the Food and Drug Administration's rising approval of new hyaluronic acid-based aesthetic fillers is expected to boost consumers' adoption of such products. For instance, in August 2023, Maypharm launched a hyaluronic acid body filler, Sedy Fill, developed with cross-linking technology for non-surgical body shape correction.
- Similarly, in June 2023, Galderma received US Food and Drug Administration approval for its advanced undereye hyaluronic acid dermal filler Restylane Eyelight, which is incorporated with NASHA technology to improve the appearance of undereye hollows due to volume loss under the eyes. The demand for hyaluronic acid is increasing, as it is an essential component that takes care of the skin. Thus, the market is expected to witness growth during the forecast period.
- Therefore, the above-mentioned factors, such as the significant advantages of hyaluronic acid fillers, therapeutic indications, and product launches, are expected to drive the segment's growth.
North America is Expected to Hold Significant Market Share During the Forecast Period
- North America is expected to contribute the highest market share in the aesthetic filler market. Factors such as the growing demands for aesthetic procedures to improve appearance, increasing awareness regarding aesthetic procedures, people focusing more on their appearance, technological advancements, and product launches fuel the market growth.
- The growing demand for aesthetic procedures contributes to market growth. For instance, in February 2023, according to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), around 82% of the aesthetic procedures performed in 2022 were minimally invasive, and the remaining 18% were surgical in the United States. Additionally, according to the International Society of Aesthetic Plastic Surgeons (ISAPS) survey released in September 2023, around 1.6 million aesthetic procedures were performed in Mexico in 2022, of which 938,096 were aesthetic surgical procedures and 755,229 were non-surgical aesthetic procedures. Furthermore, in January 2024, according to the Toronto Cosmetic Surgery Institute, around 400,000 women in Canada adopted cosmetic procedures every year. Thus, the increasing number of cosmetic procedures among the population is anticipated to boost the market's growth during the forecast period.
- Furthermore, product launches and technological advancements are anticipated to fuel the adoption rate of such products and thus boost the market growth in the region. For instance, in November 2023, the United States Patent and Trademark Office issued a patent to CollPlant Biotechnologies for photocurable dermal filler products. This polymerizable filler solution is incorporated with recombinant human collagen (rhCollagen) and hyaluronic acid, which is injected into the tissue space by applying life to induce in-situ polymerization. Additionally, in March 2024, Allergan Aesthetics, an AbbVie company, received approval from the United States Food and Drug Administration JUVÉDERM VOLUMA XC, the first and only hyaluronic acid (HA) dermal filler, for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21. Thus, such developments are likely to contribute to market growth.
- Thus, owing to these factors, such as the growing demands for aesthetic products and product launches, the aesthetic fillers market is anticipated to grow in the region.